MBL International Competitors and Similar CompaniesClear all

MBL International's competitors and similar companies include Eurobio Scientific, Urogen Pharma, Viracta Therapeutics and MedChemExpress.
MBL International
MBL International
MBL International is a life science company providing solutions for researchers in the life sciences, drug discovery and development, and clinical diagnostics fields.
Eurobio Scientific
Eurobio Scientific
Eurobio Scientific is a company that develops, produces, and markets reagents for research and biomedical diagnosis.
Urogen Pharma
Urogen Pharma
UroGen Pharma is a clinical-stage biopharmaceutical company.
Viracta Therapeutics
Viracta Therapeutics
Viracta is committed to advancing new medicines based on its viral activation therapy approach to benefit patients with viral-associated cancers and other serious diseases.
MedChemExpress
MedChemExpress
MedChemExpress (MCE) is a company offering biochemical and life science research tools.
Founding Date
Founding Date
1993
Founding Date
1997
Founding Date
2004
Founding Date
2016
Founding Date
2009
Type
Type
Subsidiary
Type
Public
Type
Public
Type
Public
Type
Private
Tags
Locations
Locations
Woburn, US HQ
Locations
Les Ulis, FR HQ
Rockville, US
Locations
New York, US HQ
Tel Aviv Yafo, IL
Princeton, US
Locations
Encinitas, US HQ
Locations
South Brunswick Township, US HQ
Employees
Employees
753% decrease
Employees
1154% increase
Employees
194362% increase
Employees
323% increase
Employees
1012% decrease
Valuation ($)
Valuation ($)
N/A
Valuation ($)
279.9 m
Valuation ($)
515.9 m
Valuation ($)
8.7 m
Valuation ($)
N/A

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
€154.2m (FY, 2024)
Revenue (est.)
$109.8m (FY, 2025)
Revenue (est.)
N/A
Revenue (est.)
N/A
Cost of goods
Cost of goods
N/A
Cost of goods
€77.2m (FY, 2024)
Cost of goods
$12.4m (FY, 2025)
Cost of goods
N/A
Cost of goods
N/A
Gross profit
Gross profit
N/A
Gross profit
€77.8m (FY, 2024)
Gross profit
$97.3m (FY, 2025)
Gross profit
N/A
Gross profit
N/A
Net income
Net income
N/A
Net income
€4m (FY, 2024)
Net income
($153.5m) (FY, 2025)
Net income
($51.1m) (FY, 2023)
Net income
N/A
For sources of this data, please see the company profile

View Company Profiles

Eurobio Scientific
HQ
Les Ulis, FR
Employees
115↑ 4% increase

Eurobio Scientific is a company that develops, produces, and markets reagents for research and biomedical diagnosis.

View company
Urogen Pharma
HQ
New York, US
Employees
194

UroGen Pharma is a clinical-stage biopharmaceutical company.

View company
Viracta Therapeutics
HQ
Encinitas, US
Employees
32↑ 3% increase

Viracta is committed to advancing new medicines based on its viral activation therapy approach to benefit patients with viral-associated cancers and other serious diseases.

View company
MedChemExpress
HQ
South Brunswick Township, US
Employees
101↓ 2% decrease

MedChemExpress (MCE) is a company offering biochemical and life science research tools.

View company